StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.87+0.26 (+5.64%)

Close on Nov 18, 2026Market cap $61.16MP/E –Yield –

Neuraxis operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Neuraxis's operating income for the twelve months ending Jun 30, 2026 was -$7.68M. For fiscal 2025 it was -$7.83M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.83M–
FY2024Dec 31, 2024-$7.16M–
FY2023Dec 31, 2023-$6.66M–
FY2022Dec 31, 2022-$3.37M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.12M–
Q1 FY2026Mar 31, 2026-$1.74M–
Q4 FY2025Dec 31, 2025-$1.72M–
Q3 FY2025Sep 30, 2025-$2.10M–
Q2 FY2025Jun 30, 2025-$1.72M–
Q1 FY2025Mar 31, 2025-$2.30M–
Q4 FY2024Dec 31, 2024-$1.47M–
Q3 FY2024Sep 30, 2024-$1.65M–
Q2 FY2024Jun 30, 2024-$2.21M–
Q1 FY2024Mar 31, 2024-$1.83M–
Q4 FY2023Dec 31, 2023-$1.62M–
Q3 FY2023Sep 30, 2023-$3.02M–
Q2 FY2023Jun 30, 2023-$1.12M–
Q1 FY2023Mar 31, 2023-$896.27K–
Q4 FY2022Dec 31, 2022-$986.23K–
Q3 FY2022Sep 30, 2022-$1.20M–
Q2 FY2022Jun 30, 2022-$669.58K–

More Neuraxis figures

See a number that looks wrong?